Uterine Manipulation Devices Market Size & Share 2026-2035

Uterine Manipulation Devices Market Size

The global uterine manipulation devices market was valued at USD 386.6 million in 2025. The market is expected to reach from USD 405.4 million in 2026 to USD 656.1 million in 2035, growing at a CAGR of 5.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

The high market growth is attributed to the rising volume of minimally invasive gynecological procedures, growing prevalence of gynecological disorders, technological advancements in device design, and increasing adoption of outpatient and ambulatory surgical settings, among other contributing factors.

Uterine manipulation devices are specialized surgical instruments used to position, mobilize, and stabilize the uterus during gynecological procedures, particularly in laparoscopic and minimally invasive surgeries. They enhance surgical access, visibility, and precision by allowing controlled movement of the uterus during procedures such as hysterectomy and pelvic surgeries.

The uterine manipulation devices market growth was driven by the rising adoption of minimally invasive gynecological procedures, increasing prevalence of uterine disorders such as fibroids and endometriosis, growing volume of hysterectomy surgeries, and continuous advancements in laparoscopic surgical technologies.

Moreover, conditions like uterine fibroids, endometriosis, and pelvic organ prolapse are seeing a high incidence, leading to more surgical interventions. For instance, according to the National Institutes of Health (NIH), uterine fibroids affect approximately 26 million women in the U.S., with an estimated 15 million experiencing symptoms severe enough to require treatment as of 2022.

Additionally, the World Health Organization (WHO) reported in 2023 that endometriosis affects roughly 10% of reproductive-age women globally. This surge underscores the growing demand for effective uterine manipulation in both diagnostic and therapeutic procedures.

Furthermore, continuous innovation in ergonomic design, single-use systems, and improved tip articulation enhances ease of use and patient safety. Advanced devices reduce procedure time, improve surgical outcomes, minimize complications, encouraging adoption among surgeons.

Uterine Manipulation Devices Market Trends

The uterine manipulation devices industry is expected to witness considerable growth due to the shift toward advanced minimally invasive and laparoscopic procedures, integration with robotic-assisted surgical systems, increasing focus on technological innovation and ergonomic design, and rising adoption of disposable and single-use devices, among other factors collectively driving industry growth.

• The introduction of single-use disposable uterine manipulators, aimed at minimizing cross-contamination, is a key factor driving product demand. Their adoption in hospitals and outpatient settings is increasing due to stringent infection control protocols. Additionally, the development of affordable yet advanced devices for low-resource settings is further supporting market growth.
• The use of lightweight, biocompatible, and sterilizable materials in reusable devices, along with the adoption of eco-friendly and high-strength plastics in disposable devices, is accelerating product adoption.
• Furthermore, the development of devices with improved ergonomics to reduce surgeon fatigue during long procedures, combined with enhanced control and precision in complex gynecological surgeries, is driving the adoption of advanced devices.

Uterine Manipulation Devices Market Analysis

Based on product type, the uterine manipulation devices market is segmented into disposable and reusable. The disposable segment has asserted its dominance in the market by securing a significant market share of 62.2% in 2025. The segment is expected to exceed USD 415.2 million by 2035, growing at a CAGR of 5.7% during the forecast period.

• Disposable uterine manipulators eliminate the risk of cross-contamination associated with reusable devices. Hospitals and surgical centers are prioritizing single-use instruments to comply with stringent infection control protocols. This is particularly critical in gynecological procedures, where sterility is essential.
• Single-use devices remove the need for complex sterilization processes, reducing operational costs related to equipment, labor, and validation. They also improve workflow efficiency by ensuring immediate availability for consecutive procedures, especially in high-volume settings.
• Moreover, disposable uterine manipulators provide uniform quality and performance for every procedure, unlike reusable devices that may degrade over time. This consistency enhances surgical precision and reduces the likelihood of device-related complications.
• The reusable segment held a revenue of USD 146.2 million in 2025, with projections indicating a steady expansion at a CAGR of 5.2% from 2026 to 2035. The segment is driven by their long-term cost efficiency and reduced per-procedure expenditure, making them suitable for high-volume surgical centers. Additionally, growing focus on sustainability, reduced medical waste, and improved durability with advanced sterilization compatibility is supporting their continued adoption.

Based on application, the uterine manipulation devices market is classified into total laparoscopy hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), laparoscopically assisted vaginal hysterectomy (LAVH), and other applications. The total laparoscopy hysterectomy (TLH) segment dominated the market with a revenue share of 44.5% in 2025 and is expected to reach USD 298.9 million within the forecast period.

• Total laparoscopic hysterectomy (TLH) is increasingly favored over open and vaginal approaches due to reduced postoperative pain, shorter hospital stays, and faster recovery. This shift directly increases the use of uterine manipulation devices, which are essential for uterine positioning and exposure during laparoscopic procedures.
• Continuous improvements in laparoscopic systems, imaging, and uterine manipulators have enhanced surgical precision and ease of use. Advanced manipulators with better articulation and control improve access to anatomical structures, supporting wider adoption of TLH among surgeons.
• The laparoscopic supracervical hysterectomy (LSH) segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.6% over the forecast period. The segment is driven by its clinical benefits such as reduced operative time, lower complication rates, and preservation of cervical support, improving postoperative outcomes. Additionally, increasing surgeon preference for uterus-conserving approaches and faster patient recovery is supporting higher procedure adoption.
• The laparoscopically assisted vaginal hysterectomy (LAVH) segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 4.9% over the forecast period. The segment is driven by its ability to combine laparoscopic visualization with vaginal removal, enabling better management of complex cases such as adhesions or enlarged uterus. Additionally, reduced hospital stay and improved surgical flexibility are supporting its increasing preference among surgeons.

• Hospitals remain the primary centers for complex and high-volume gynecological procedures, including hysterectomy, myomectomy, and endometriosis treatment. The consistent influx of such cases drives steady demand for uterine manipulation devices. Their role in improving surgical access and precision makes them indispensable in operating rooms.
• Hospitals are equipped with advanced laparoscopic and robotic surgical systems, enabling a wide range of minimally invasive procedures. This infrastructure supports the routine use of uterine manipulators for better visualization and control during surgery. As hospitals upgrade technology, device adoption continues to rise.
• The gynecology clinics segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 5.8% over the forecast period. Growth in this segment is driven by increasing decentralization of women’s healthcare services and rising preference for specialized, clinic-based surgical care. Additionally, shorter wait times, personalized treatment, and expansion of minimally invasive capabilities in clinic settings are boosting procedure volumes and device demand.
• The ambulatory surgery centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.1% over the forecast period. The segmental growth is driven by their lower procedural costs, faster patient throughput, and favorable reimbursement structures compared to hospitals. Additionally, increasing shift of gynecological surgeries to day-care settings and operational efficiency is boosting demand for uterine manipulation devices.

North America Uterine Manipulation Devices Market

North America dominated the uterine manipulation devices industry with the highest market share of 33.5% in 2025.

• The U.S. uterine manipulation devices industry size reached USD 121.6 million in 2025, growing from USD 116.3 million in 2024, and is anticipated to grow at a CAGR of 4.7% from 2026 to 2035.
• North America, particularly the U.S., demonstrates strong penetration of laparoscopic and robotic-assisted gynecological procedures. Hospitals widely utilize advanced uterine manipulators to enhance precision and visualization. The integration of robotic platforms further increases dependency on high-performance devices. This technological maturity sustains consistent demand across large healthcare systems.
• Well-established reimbursement frameworks for gynecological procedures encourage higher surgical volumes. Public and private insurers cover hysterectomies and related interventions, reducing patient financial burden. High per capita healthcare spending supports procurement of premium disposable and reusable manipulators. This ensures continuous adoption of advanced products.

Europe Uterine Manipulation Devices Market

Europe uterine manipulation devices industry accounted for USD 119.7 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Countries such as Germany and UK are emphasizing outpatient and short-stay surgical models. Minimally invasive hysterectomies are increasingly performed in such settings. This drives demand for easy-to-use, efficient uterine manipulators that support faster procedures. The shift improves operational efficiency across healthcare systems.
• Strict regulatory frameworks ensure high standards for surgical instruments and infection control. Healthcare providers prefer certified, high-quality uterine manipulators to comply with safety norms. This promotes adoption of technologically advanced and disposable devices. Regulatory rigor indirectly elevates market value.

Asia Pacific Uterine Manipulation Devices Market

The Asia Pacific uterine manipulation devices industry is anticipated to grow at the highest CAGR of 6.4% during the analysis timeframe.

• Asia Pacific has become a hub for cost-effective surgical treatments, attracting international patients. Countries such as Thailand and India offer advanced laparoscopic hysterectomies at competitive prices. Increased procedure volumes from medical tourists drive device consumption. This trend strengthens regional market growth.
• Surgeons across the region are increasingly adopting laparoscopic and robotic-assisted procedures. Training programs and international collaborations are improving surgical expertise. This transition requires effective uterine manipulation tools for precision. Adoption is accelerating in both public and private hospitals.

Latin America Uterine Manipulation Devices Market

The Latin America uterine manipulation devices industry is experiencing robust growth over the analysis timeframe.

• Countries such as Brazil and Mexico are expanding healthcare coverage and infrastructure. Increased access to gynecological care is driving higher surgical volumes. Public and private hospitals are adopting minimally invasive techniques. This fuels demand for uterine manipulation devices.
• There is a gradual shift from open surgeries to laparoscopic procedures across the region. Hospitals are upgrading equipment and training surgeons in minimally invasive techniques. Uterine manipulators are becoming essential tools in these procedures. This transition supports steady market growth.

Middle East & Africa Uterine Manipulation Devices Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• Nations such as Saudi Arabia and UAE are heavily investing in healthcare infrastructure. Development of advanced hospitals and specialty centers is increasing surgical capacity. This drives adoption of modern gynecological instruments, including uterine manipulators.
• The Middle East is emerging as a destination for high-quality medical care, particularly in the UAE. International patients seek minimally invasive gynecological procedures. Increased procedure volumes support demand for advanced surgical devices. This trend enhances regional market growth.

Uterine Manipulation Devices Market Share

The global uterine manipulation devices industry is moderately competitive, characterized by the presence of established global medical device manufacturers alongside specialized gynecological instrument providers. Companies compete on product innovation, ergonomic design, pricing strategies, and integration with minimally invasive surgical systems, while maintaining strong distribution networks across developed and emerging markets. Key players include CooperSurgical, KARL STORZ, CONMED, B. BRAUN, and RICHARD WOLF, collectively accounting for ~68% of the total market share.

Market participants are increasingly focusing on expanding their product portfolios through technological advancements, including disposable variants and compatibility with advanced laparoscopic and robotic platforms. Strategic initiatives such as mergers, acquisitions, and geographic expansion are further intensifying competition and strengthening market positioning.

Uterine Manipulation Devices Market Companies

A few of the prominent players operating in the uterine manipulation devices industry include:

• Aspen Surgical
• B. BRAUN
• Bissinger Medizintechnik
• CONKIN SURGICAL INSTRUMENTS
• CONMED
• CooperSurgical
• EndoMed Systems
• KARL STORZ
• Laborie
• LSI SOLUTIONS
• Peters Surgical
• Progressive Medical
• Purple Surgical
• RICHARD WOLF
• UTAH MEDICAL PRODUCTS
• CooperSurgical

Strong specialization in women’s health, with a comprehensive portfolio of uterine manipulators tailored for diverse gynecological procedures. Emphasis on clinician-friendly designs and continuous product innovation strengthens adoption across hospitals and outpatient settings.

• KARL STORZ

Renowned for precision-engineered instruments integrated with advanced endoscopic visualization systems for enhanced surgical control. Focus on high-quality, reusable devices with superior ergonomics supports efficiency in complex laparoscopic procedures.

• CONMED

It offers a balanced portfolio of cost-effective and technologically advanced surgical devices suited for minimally invasive gynecology. A strong global distribution network and focus on procedural efficiency drive widespread adoption in high-volume surgical centers.

Uterine Manipulation Devices Industry News

• In June 2023, The Asociación RUVID researchers, in collaboration with the Abdomino-Pelvic Oncology Surgery Department at General University Hospital of Castelló and Fisabio Foundation, have developed an atraumatic uterine manipulator for minimally invasive gynecological surgery. The device is designed to enable surgical procedures without causing damage to existing cervical tumors during intervention. Following completion of ongoing studies and regulatory approval, the team plans to commercialize the device for use in laparoscopic and robotic surgical procedures.

The uterine manipulation devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Disposable
• Reusable

Market, By Application

• Total laparoscopy hysterectomy (TLH)
• Laparoscopic supracervical hysterectomy (LSH)
• Laparoscopically assisted vaginal hysterectomy (LAVH)
• Other applications

Market, By End Use

• Hospitals
• Gynecology clinics
• Ambulatory surgery centers

he above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE